We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current AVCR market cap is 13.4M. The company's latest EPS is CAD -0.0082 and P/E is -15.85.
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 827k | 134k | 33k | 123k | 1.77M |
| Operating Income | -2.91M | -998k | -214k | -929k | -300k |
| Net Income | -4.14M | -2.11M | -1.17M | -1.71M | -818k |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 1.2M | 208k | 440k | 2.28M | 2.57M |
| Total Liabilities | 314k | 673k | 1.15M | 84k | 605k |
| Total Equity | 886k | -465k | -713k | 2.2M | 1.96M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -1.73M | -687k | -1.22M | -1.24M | -438k |
| Investing | -155k | N/A | N/A | -140k | -1.21M |
| Financing | 1.41M | 616k | 1.51M | 3.09M | 254k |
| Market Cap | 13.4M |
| Price to Earnings Ratio | -15.85 |
| Price to Sales Ratio | 7.3 |
| Price to Cash Ratio | 20.63 |
| Price to Book Ratio | 6.57 |
| Dividend Yield | - |
| Shares Outstanding | 99.24M |
| Average Volume (1 week) | 15.31k |
| Average Volume (1 Month) | 32.38k |
| 52 Week Change | -54.24% |
| 52 Week High | 0.30 |
| 52 Week Low | 0.105 |
| Spread (Intraday) | 0.01 (3.57%) |
| Company Name | Avricore Health Inc |
| Address |
700 – 1199 west hastings street vancouver, british columbia V6E 3T5 |
| Website | https://www.avricorehealth.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
